Wei Ying, Ma Chao-Mei, Hattori Masao
Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Eur J Med Chem. 2009 Oct;44(10):4112-20. doi: 10.1016/j.ejmech.2009.05.002. Epub 2009 May 15.
2,3-Seco-dioic acids derived from four different triterpene skeletons were prepared and evaluated for their anti-HIV-1 protease activity. Two A-seco derivatives showed potent inhibitory activity against HIV-1 protease (3c and 3e, IC(50) 5.7 and 3.9 microM, respectively), while four other derivatives showed moderate to weak inhibition (3a, 3b, 3d and 3f, IC(50) 15.7-88.1 microM). The combination of a 2,3-seco-2,3-dioic acid functional group in ring A and a free acid group at C-28 or C-30 significantly enhanced HIV-1 protease inhibitory activity (3a, 3c-3e, IC(50) 3.9-17.6 microM). On the other hand, all A-seco derivatives were found to be very weak inhibitors of HCV, renin and trypsin proteases (IC(50)>80 microM). These findings indicate that A-seco triterpenes with a carboxyl group at C-28 or C-30 are novel and highly selective HIV-1 protease inhibitors.
制备了源自四种不同三萜骨架的2,3-断-二羧酸,并对其抗HIV-1蛋白酶活性进行了评估。两种A-断衍生物对HIV-1蛋白酶表现出强效抑制活性(3c和3e,IC(50)分别为5.7和3.9 microM),而其他四种衍生物表现出中度至弱抑制作用(3a、3b、3d和3f,IC(50)为15.7 - 88.1 microM)。A环中2,3-断-2,3-二羧酸官能团与C-28或C-30处的游离酸基团的组合显著增强了HIV-1蛋白酶抑制活性(3a、3c - 3e,IC(50)为3.9 - 17.6 microM)。另一方面,发现所有A-断衍生物都是HCV、肾素和胰蛋白酶蛋白酶的非常弱的抑制剂(IC(50)>80 microM)。这些发现表明,在C-28或C-30处带有羧基的A-断三萜是新型且高度选择性的HIV-1蛋白酶抑制剂。